Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 312.50 | 129.17 | 104.00 | 202.25 | 0.5142 | -0.2847 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 163.00 | 202.25 | 0.8059 | 0.4328 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 97.00 | 202.25 | 0.4796 | -0.3577 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 506.00 | 580.00 | 0.8724 | 0.7663 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 467.00 | 580.00 | 0.8052 | 0.6420 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 523.00 | 580.00 | 0.9017 | 0.8203 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 625.00 | 270.83 | 583.00 | 580.00 | 1.0052 | 1.0094 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 625.00 | 270.83 | 799.00 | 580.00 | 1.3776 | 1.6771 |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 625.00 | 270.83 | 808.00 | 580.00 | 1.3931 | 1.7045 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 825.00 | 580.00 | 1.4224 | 1.7562 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 625.00 | 270.83 | 767.00 | 580.00 | 1.3224 | 1.5793 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 625.00 | 270.83 | 851.00 | 580.00 | 1.4672 | 1.8352 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 625.00 | 270.83 | 948.00 | 580.00 | 1.6345 | 2.1279 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 826.00 | 580.00 | 1.4241 | 1.7593 | |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 625.00 | 270.83 | 253.00 | 580.00 | 0.4362 | -0.0601 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 625.00 | 270.83 | 851.00 | 580.00 | 1.4672 | 1.8352 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 737.00 | 580.00 | 1.2707 | 1.4873 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 745.00 | 580.00 | 1.2845 | 1.5119 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 625.00 | 270.83 | 823.00 | 580.00 | 1.4190 | 1.7501 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 791.00 | 580.00 | 1.3638 | 1.6526 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 756.00 | 580.00 | 1.3034 | 1.5456 |
| BT-20 | Erlotinib | 1 | uM | 8 | 625.00 | 270.83 | 585.00 | 580.00 | 1.0086 | 1.0157 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 625.00 | 270.83 | 633.00 | 580.00 | 1.0914 | 1.1657 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 530.00 | 580.00 | 0.9138 | 0.8424 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 625.00 | 270.83 | 243.00 | 580.00 | 0.4190 | -0.0940 |